Another study highlighted the importance of phospho-eIF4E in promoting the post-translational regulation of CTNNB1 (encodes β-catenin) in chronic myelogenous leukemia (CML) cells and, thereby, preventing the rise of therapy-resistant stem cells [106]. This evidence concerns the gene CTNNB1 and chronic myelogenous leukemia, BCR-ABL1 positive.